PPP1R10

Serine/threonine-protein phosphatase 1 regulatory subunit 10 · Q96QC0 · PPP1R10 on Sugi Atlas →

0 patent compounds predicted against PPP1R10, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PPP1R10 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis PHASE4COMPLETED
Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma PHASE4UNKNOWN
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer PHASE1/PHASE2COMPLETED
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Open-label Study on Treatment of Primary Aldosteronism With Everolimus PHASE2COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Immune Signature of Palmoplantar Pustulosis nanCOMPLETED
NGS in Gallbladder Cancer and Response to Treatment nanRECRUITING
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
CircularRNA-microRNA-mRNA Regulatory Axis in IVF nanNOT_YET_RECRUITING
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer nanCOMPLETED
Vulvodynia: Identification of Potential Relevant Biomarkers nanCOMPLETED
Biomarkers in Samples From Patients With Endometrial Cancer nanWITHDRAWN
Protein Intake and Step Reduction in Older Adults nanCOMPLETED
Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Generating Intervals of Reference FFor Early Life Brain Biomarkers. nanRECRUITING
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Gene Expression in Inflammatory Bowel Disease nanENROLLING_BY_INVITATION

Related proteins — ESM-2 sequence neighbours (a PPP1R10 binder may also engage these)

ProteinNameSimilarity
Q5TM61 1.000 Q5TM61 →
Q767K9 1.000 Q767K9 →
Q7YR38 1.000 Q7YR38 →
Q80W00 1.000 Q80W00 →
O55000 1.000 O55000 →
Q6GLQ4 1.000 Q6GLQ4 →
P97868 0.993 P97868 →
Q80TZ9 0.991 Q80TZ9 →
Q9VIV2 0.991 Q9VIV2 →
Q9NRR4 0.990 Q9NRR4 →
Q62901 0.989 Q62901 →
Q63627 0.989 Q63627 →
O95104 0.989 O95104 →
Q5HZJ0 0.989 Q5HZJ0 →
Q8K0V4 0.989 Q8K0V4 →
P0CB49 0.988 P0CB49 →
Q9LV14 0.988 Q9LV14 →
Q9P2R6 0.988 Q9P2R6 →
Q9R0I7 0.988 Q9R0I7 →
O94913 0.988 O94913 →
Q62431 0.987 Q62431 →
Q8MQH7 0.987 Q8MQH7 →
P41846 0.987 P41846 →
Q7TN99 0.987 Q7TN99 →
Q8CGZ0 0.987 Q8CGZ0 →
Q6PEI3 0.987 Q6PEI3 →
Q6NYG6 0.987 Q6NYG6 →
Q6IZA3 0.987 Q6IZA3 →
Q95XU6 0.987 Q95XU6 →
SETD1B Histone-lysine N-methyltransferase SETD1B 0.987 landscape →